NLRP3 and tauopathy: Antagonizing purinoreceptor (P2 × 7R) to prevent the assembly of an active NLRP3 inflammasome in microglia has been suggested as one of the best approaches to control neuroinflammation caused by microglial activation and has therapeutic potential for treating tauopathies [109,110].